The microglial P2Y6 receptor as a therapeutic target for neurodegenerative diseases

被引：2
|
作者：
Dundee, Jacob M. [1 ]
Brown, Guy C. [1 ]
机构：
[1] Univ Cambridge, Dept Biochem, Cambridge, England
来源：
TRANSLATIONAL NEURODEGENERATION | 2024年 / 13卷 / 01期
基金：
英国医学研究理事会;
关键词：
Alzheimer's disease; Parkinson's disease; Neurodegeneration; Neuroinflammation; P2Y(6) receptor; Drug development; Microglia; NEURONAL DEATH; ALZHEIMERS-DISEASE; ALPHA-SYNUCLEIN; PROTEIN-KINASE; BINDING SITES; AMYLOID-BETA; PHAGOCYTOSIS; ACTIVATION; MODEL; INHIBITION;
D O I：
10.1186/s40035-024-00438-5
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
Neurodegenerative diseases are associated with chronic neuroinflammation in the brain, which can result in microglial phagocytosis of live synapses and neurons that may contribute to cognitive deficits and neuronal loss. The microglial P2Y(6) receptor (P2Y(6)R) is a G-protein coupled receptor, which stimulates microglial phagocytosis when activated by extracellular uridine diphosphate, released by stressed neurons. Knockout or inhibition of P2Y(6)R can prevent neuronal loss in mouse models of Alzheimer's disease (AD), Parkinson's disease, epilepsy, neuroinflammation and aging, and prevent cognitive deficits in models of AD, epilepsy and aging. This review summarises the known roles of P2Y(6)R in the physiology and pathology of the brain, and its potential as a therapeutic target to prevent neurodegeneration and other brain pathologies.
引用
收藏
页数：11
相关论文
共 50 条
  • [21] Essential role of P2Y6 receptor in vascular contraction-lessons from P2Y6 knockout mice
    Kauffenstein, Gilles
    Loufrani, Laurent
    Sevigny, Jean
    Robaye, Bernard
    Henrion, Daniel
    PURINERGIC SIGNALLING, 2010, 6 : 64 - 64
  • [22] Neuropeptide Y (NPY) as a therapeutic target for neurodegenerative diseases
    Duarte-Neves, Joana
    de Almeida, Luis Pereira
    Cavadas, Claudia
    NEUROBIOLOGY OF DISEASE, 2016, 95 : 210 - 224
  • [23] P2X7 Receptor Signaling Pathway as a Therapeutic Target for Neurodegenerative Diseases
    Takenouchi, Takato
    Sekiyama, Kazunari
    Sekigawa, Akio
    Fujita, Masayo
    Waragai, Masaaki
    Sugama, Shuei
    Iwamaru, Yoshifumi
    Kitani, Hiroshi
    Hashimoto, Makoto
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2010, 58 (02) : 91 - 96
  • [24] P2X7 Receptor Signaling Pathway as a Therapeutic Target for Neurodegenerative Diseases
    Takato Takenouchi
    Kazunari Sekiyama
    Akio Sekigawa
    Masayo Fujita
    Masaaki Waragai
    Shuei Sugama
    Yoshifumi Iwamaru
    Hiroshi Kitani
    Makoto Hashimoto
    Archivum Immunologiae et Therapiae Experimentalis, 2010, 58 : 91 - 96
  • [25] Attenuation of β-cell death by P2Y6 receptor agonist: A novel drug target for diabetes
    Balasubramanian, Ramachandran
    De Castro, Sonia
    Maruoka, Hirsohi
    Jacobson, Kenneth A.
    FASEB JOURNAL, 2010, 24
  • [26] P2Y6 receptor-dependent microglial phagocytosis of synapses mediates synaptic and memory loss in aging
    Dundee, Jacob M.
    Puigdellivol, Mar
    Butler, Richard
    Cockram, Thomas O. J.
    Brown, Guy C.
    AGING CELL, 2023, 22 (02)
  • [27] Lack of specificity shown by P2Y6 receptor antibodies
    Weiqun Yu
    Warren G. Hill
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2013, 386 : 885 - 891
  • [28] Evidence that the p2y3 receptor is the avian homologue of the mammalian P2Y6 receptor
    Li, Q
    Olesky, M
    Palmer, RK
    Harden, TK
    Nicholas, RA
    MOLECULAR PHARMACOLOGY, 1998, 54 (03) : 541 - 546
  • [29] CELLULAR LOCALIZATION OF P2Y6 RECEPTOR IN RAT RETINA
    Zhang, P. P.
    Yang, X. L.
    Zhong, Y. M.
    NEUROSCIENCE, 2012, 220 : 62 - 69
  • [30] P2Y6 receptor mediates the constitutive pinocytosis in astrocytes
    Nasu-Tada, K
    Tozaki-Saitoh, H
    Inoue, K
    Koizumi, S
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2006, 100 : 199P - 199P
12345